戻る Agenda
Update on PMDA’s Activities
Session Chair(s)
Nobumasa Nakashima
Professor
Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Japan
In this session, PMDA will share the latest details regarding its policies and initiatives and other related strategic directives. The goal of the session will be to keep participants informed of the agency’s handling of the most critical issues facing Japanese and global stakeholders. The session will also include time for Q&A.
Speaker(s)
PMDA’s Regulatory Science and Innovation
Tatsuya Kondo, MD, PHD
SH Medical Excellence JAPAN, Japan
President
Regulatory Updates – Facilitating Early Patient Access
Kenichi Mikami, MPHARM, MS
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Office Director, Office of Review Management
Real World Data Utilisation: PMDA’s Approach to Pharmacovigilance
Daisaku Sato, PHD, MPHARM, RPH
Ministry of Health, Labour and Welfare, Japan
Councilor for Pharmaceutical Affairs